Biodesix Inc [NASDAQ: BDSX] closed the trading session at $0.42 on 2025-09-03. The day’s price range saw the stock hit a low of $0.4105, while the highest price level was $0.44.
The stocks have a year to date performance of -77.19 percent and weekly performance of -9.25 percent. The stock has been moved at -41.39 percent over the last six months. The stock has performed 9.84 percent around the most recent 30 days and changed 40.39 percent over the most recent 3-months.
If compared to the average trading volume of 1.44M shares, BDSX reached to a volume of 3061201 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Biodesix Inc [BDSX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BDSX shares is $1.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BDSX stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Biodesix Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on May 14, 2025. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on September 16, 2024, representing the official price target for Biodesix Inc stock. Previously, the target price had yet another raise to $3, while Craig Hallum analysts kept a Buy rating on BDSX stock.
The Price to Book ratio for the last quarter was 54.38, with the Price to Cash per share for the same quarter was set at 0.14.
BDSX stock trade performance evaluation
Biodesix Inc [BDSX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.25. With this latest performance, BDSX shares gained by 9.84% in over the last four-week period, additionally sinking by -41.39% over the last 6 months – not to mention a drop of -72.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BDSX stock in for the last two-week period is set at 51.62, with the RSI for the last a single of trading hit 0.0384, and the three-weeks RSI is set at 0.0398 for Biodesix Inc [BDSX]. The present Moving Average for the last 50 days of trading for this stock 0.3687, while it was recorded at 0.4397 for the last single week of trading, and 0.7244 for the last 200 days.
Biodesix Inc [BDSX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Biodesix Inc [BDSX] shares currently have an operating margin of -44.27% and a Gross Margin at 78.77%. Biodesix Inc’s Net Margin is presently recorded at -53.66%.
Biodesix Inc (BDSX) Capital Structure & Debt Analysis
According to recent financial data for Biodesix Inc. ( BDSX), the Return on Equity (ROE) stands at -219.68%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -40.36%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Biodesix Inc’s Return on Invested Capital (ROIC) is -57.03%, showcasing its effectiveness in deploying capital for earnings.
Biodesix Inc (BDSX) Efficiency & Liquidity Metrics
Based on Biodesix Inc’s (BDSX) latest financial statements, the Debt-to-Equity Ratio is 63.28%, indicating its reliance on debt financing relative to shareholder equity.
Biodesix Inc (BDSX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Biodesix Inc. (BDSX) effectively leverages its workforce, generating an average of -$150476.19 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.14% and a Quick Ratio of 2.03%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Biodesix Inc [BDSX] stock
With the latest financial reports released by the company, Biodesix Inc posted -0.07/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BDSX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Biodesix Inc go to 31.73%.
Biodesix Inc [BDSX]: Institutional Ownership
There are presently around $24.32%, or 50.80%% of BDSX stock, in the hands of institutional investors. The top three institutional holders of BDSX stocks are: TELEMARK ASSET MANAGEMENT, LLC with ownership of 8.28 million shares, which is approximately 6.513%. SOLEUS CAPITAL MANAGEMENT, L.P., holding 6.11 million shares of the stock with an approximate value of $$9.35 million in BDSX stocks shares; and SOLEUS CAPITAL MANAGEMENT, L.P., currently with $$8.84 million in BDSX stock with ownership which is approximately 4.545%.
